Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Medanta

    Jump to

    • Global Health Q2 FY26: Healthy performance, strong outlook

      The upcoming greenfield projects will help Medanta to establish a presence in western and eastern India

    • Max Healthcare, Medanta, KIMS among key beneficiaries from CGHS rates revision, can see 22% jump in EBITDA

      The CGHS revision is positive for private healthcare operators and will disproportionately benefit super-specialty hospitals, noted analysts.

    • Global Health: In the pink of health, but growth will come at a price

      Demand for high-end healthcare facilities remains strong; however, the company’s valuation appears demanding

    • Optimism low on this healthcare stock

      Medanta has strong capabilities to leverage its brand image. However, near-term growth looks limited

    • Medanta to invest Rs 500 cr to set up 400-bed hospital in Guwahati

      The company's board, in its meeting held on Monday, has approved the purchase of 3 acres of land from Assam Electricity Grid Corporation Ltd for Rs 30 crore plus incidental expenses for registration and possession of the land, the healthcare provider said in a regulatory filing.

    • Medanta: New facilities gradually stabilising; remain constructive

      Encouraged by the demand-supply gap in healthcare needs in the hinterland, the company continues to add bed capacities

    • Medanta: Time to check out this healthcare theme

      It is a play on the growing importance of regional health hubs in the northern and eastern states.

    • Medanta: Charting a growth path

      Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.

    • MHADA sells 2-acre plot in Mumbai to Medanta for Rs 125 crore

      The Maharashtra Housing and Area Development Authority had set a reserve price of Rs 67.5 crore for the plot in Oshiwara

    • Medanta: Why the recent stock correction offers value

      Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.

    • Medanta stock tanks 13% in 3 days after strong Q4 results, as margin, valuation concerns weigh

      Even though long-term growth prospects remain intact for Global Health, slow near-term margin expansion due to consistent capex, along with the pricey valuations of the stock has triggered a selloff in the counter.

    • Private hospitals poised for growth on rising healthcare spends, market share, expansion plans: Anand Rathi

      Anand Rathi predicts private hospitals will dominate India's healthcare system as government funding falls short. It recommends buy on Max Healthcare, Rainbow Children’s Medicare, KIMS and Jupiter Life Line Hospitals,

    • GPT Healthcare IPO: Play on eastern India’s healthcare demand

      What makes this IPO interesting is that eastern India has the lowest concentration of medical specialists among all the regions in India. Further, the company‘s key market, Kolkata, has the lowest bed density across Tier 1 cities.

    • Temasek divests 1.1% stake in Medanta for Rs 395 crore: Report

      Temasek invested about Rs 700 crore in January 2015 to acquire almost 18% stake in the hospital chain

    • Medanta: Still more to offer

      Medanta has a solid footing in the NCR region and is focused on widening its reach in the underserved Tier II markets

    • Medanta share jump lifts its chief and surgeon Naresh Trehan to billionaire list

      With this, Trehan, 77, has become India’s richest professional manager with his net worth surging past Rs 8,402.30 crore or $1 billion.

    • Medanta Q2 results: Net Profit up 46% to Rs 125 crore

      Medanta Q2 earnings: The hospital operator's revenue for the quarter came in at Rs 844 crore, reflecting a 24 percent rise YoY from Rs 679 crore

    • Global Health-Medanta jumps 3% on 'buy' rating from Motilal Oswal

      "The company's growth momentum will be led by higher volume of patients being treated at new hospitals, scale-up in international patient flow, and improvement in the average revenue per occupied bed backed by superior payor mix/case mix," Motilal Oswal Financial Services said.

    • Global Health: Ramp-up in new hospitals to support earnings growth

      Medanta is cementing its footprint in north India. Its aggressive expansion plans reflect the growing demand and the opportunities for high-end healthcare facilities in the country

    • Medanta trades higher, Jefferies retains 'buy' on growth visibility

    • Hospital sector likely to firm up on higher occupancy, favourable base in Q4

    • Covid spike to stabilise in two weeks, need to assess vaccine efficacy, develop new shots: Dr Guleria

    • Be Patient: Jefferies sees regulatory snags as buying opportunity in hospital stocks

    • Medanta operator Global Health surges 19% on debut

    • Medanta to debut today | Will it make investors happy?

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347